These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12789260)

  • 1. Triggering of p73-dependent apoptosis in osteosarcoma is under the control of E2Fs-pRb2/p130 complexes.
    La Sala D; Macaluso M; Trimarchi C; Giordano A; Cinti C
    Oncogene; 2003 Jun; 22(23):3518-29. PubMed ID: 12789260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
    Macaluso M; Cinti C; Russo G; Russo A; Giordano A
    Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation.
    Vairo G; Soos TJ; Upton TM; Zalvide J; DeCaprio JA; Ewen ME; Koff A; Adams JM
    Mol Cell Biol; 2000 Jul; 20(13):4745-53. PubMed ID: 10848600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
    Raschellà G; Tanno B; Bonetto F; Amendola R; Battista T; De Luca A; Giordano A; Paggi MG
    J Cell Biochem; 1997 Dec; 67(3):297-303. PubMed ID: 9361185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
    Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A
    Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation.
    Pucci B; Claudio PP; Masciullo V; Bellincampi L; Terrinoni A; Khalili K; Melino G; Giordano A
    Oncogene; 2002 Aug; 21(38):5897-905. PubMed ID: 12185589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta inhibits the phosphorylation of pRB at multiple serine/threonine sites and differentially regulates the formation of pRB family-E2F complexes in human myeloid leukemia cells.
    Hu X; Cress WD; Zhong Q; Zuckerman KS
    Biochem Biophys Res Commun; 2000 Oct; 276(3):930-9. PubMed ID: 11027571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus.
    Zini N; Trimarchi C; Claudio PP; Stiegler P; Marinelli F; Maltarello MC; La Sala D; De Falco G; Russo G; Ammirati G; Maraldi NM; Giordano A; Cinti C
    J Cell Physiol; 2001 Oct; 189(1):34-44. PubMed ID: 11573202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the p53-homologue p73 in E2F1-induced apoptosis.
    Stiewe T; Pützer BM
    Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E1A activates transcription of p73 and Noxa to induce apoptosis.
    Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M
    J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ; Schaley JE; Feeney G; Hearing P
    Oncogene; 2001 Apr; 20(15):1882-91. PubMed ID: 11313936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.
    Marabese M; Vikhanskaya F; Rainelli C; Sakai T; Broggini M
    Nucleic Acids Res; 2003 Nov; 31(22):6624-32. PubMed ID: 14602923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
    Stiegler P; De Luca A; Bagella L; Giordano A
    Cancer Res; 1998 Nov; 58(22):5049-52. PubMed ID: 9823308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y; Iwase S; Kikuchi J; Nakamura M; Yamada H; Matsuda M
    Oncogene; 1999 Mar; 18(11):2003-14. PubMed ID: 10208422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications.
    Russo G; Zamparelli A; Howard CM; Minimo C; Bellan C; Carillo G; Califano L; Leoncini L; Giordano A; Claudio PP
    Clin Cancer Res; 2005 May; 11(9):3265-73. PubMed ID: 15867222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation.
    Lissy NA; Davis PK; Irwin M; Kaelin WG; Dowdy SF
    Nature; 2000 Oct; 407(6804):642-5. PubMed ID: 11034214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.
    Nicholson SA; Okby NT; Khan MA; Welsh JA; McMenamin MG; Travis WD; Jett JR; Tazelaar HD; Trastek V; Pairolero PC; Corn PG; Herman JG; Liotta LA; Caporaso NE; Harris CC
    Cancer Res; 2001 Jul; 61(14):5636-43. PubMed ID: 11454718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins.
    Hateboer G; Kerkhoven RM; Shvarts A; Bernards R; Beijersbergen RL
    Genes Dev; 1996 Dec; 10(23):2960-70. PubMed ID: 8956997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels.
    Jiang H; Karnezis AN; Tao M; Guida PM; Zhu L
    Oncogene; 2000 Aug; 19(34):3878-87. PubMed ID: 10951581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human p73 promoter: characterization and identification of functional E2F binding sites.
    Seelan RS; Irwin M; van der Stoop P; Qian C; Kaelin WG; Liu W
    Neoplasia; 2002; 4(3):195-203. PubMed ID: 11988839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.